Politics

UK Is First To Approve ‘Next Generation’ Covid Vaccine That Targets Omicron

The UK has become the first nation to approve a “next generation” Covid-19 booster jab which will target two strains of the virus simultaneously.

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Moderna’s bivalent vaccine, which targets both the original Covid strain and the Omicron variant.

Known as mRNA-1273.214, the dose is an updated version of the Moderna vaccine which is already in use for first, second and booster doses.

Moderna’s chief medical officer, Dr Paul Burton, previously said that the new jab can boost a person’s antibodies to such high levels that it may only be needed annually.

Stephane Bancel, chief executive officer at Moderna, described it as a “next generation Covid-19 vaccine” which will play an “important role in protecting people in the UK from Covid-19” over the winter.

He added that the jab has “consistently shown superior breadth of immune response” over alternatives in clinical trials.

The MHRA said that the vaccine’s side effects are the same as those seen in the original Moderna booster dose and were typically mild.

Its chief executive, Dr June Raine, described the new booster as “a sharpened tool in our armoury” to protect the UK against Covid-19.



Most Related Links :
todayuknews Governmental News Finance News

Source link

Back to top button